Immunocytochemistry of neurotropic melanoma
- 15 January 1984
- Vol. 53 (2) , 254-257
- https://doi.org/10.1002/1097-0142(19840115)53:2<254::aid-cncr2820530212>3.0.co;2-o
Abstract
Schwann cell differentiation has been proposed in the histogenesis of neurotropic melanoma by light and electron microscopic studies, and melanosomes are rarely, if ever, detected in the spindle cell component of this tumor. S-100 immunoreactivity has previously been demonstrated in Schwann cells of benign neurogenic tumors and most malignant melanomas. The authors report S-100 immunoreactivity in spindle cell elements of neurotropic melanoma. Focal neuron-specific enolase immunoreactivity was also found. These findings, in the absence of melanosomes in tumor cells, support the contention that the spindle cell element of neurotropic melanoma is derived from cells of neural crest origin.This publication has 22 references indexed in Scilit:
- Acral lentiginous melanoma simulating “clear cell sarcoma of tendon and aponeuroses”Journal of Cutaneous Pathology, 1983
- A NEW MARKER FOR HUMAN CANCER CELLS. 2. IMMUNOHISTOCHEMICAL DETECTION OF THE Ca ANTIGEN IN HUMAN TISSUES WITH THE Ca1 ANTIBODYThe Lancet, 1982
- Neurotropic melanoma of the vulvaCancer, 1982
- Distribution of S-100 protein outside the central nervous systemBrain Research, 1982
- Peripheral nerve sheath tumors: An electron microscopic study of 43 casesCancer, 1982
- Neurotropic melanomaThe American Journal of Surgical Pathology, 1979
- Clear cell sarcoma of tendons and aponeuroses.A comparative study of 13 cases with a provisional subgrouping into the melanotic and synovial typesCancer, 1978
- Immunohistochemical localisation of S–100 protein in brainNature, 1975
- Demonstration of Enolase Activity Connected to the Brain‐Specific Protein 14‐3‐2Scandinavian Journal of Immunology, 1975
- A soluble protein characteristic of the nervous systemBiochemical and Biophysical Research Communications, 1965